reference/3157835

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3157835

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural
endingPage	2969
issn	1522-9645 0195-668X
issueIdentifier	23
pageRange	2962-2969
publicationName	European Heart Journal
startingPage	2962
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1dbc48d401ff4ad36ae9be0cc574230f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_452f792b7608fabb39df4eb370cb3b98
bibliographicCitation	Dorresteijn JA, Visseren FL, Ridker PM, Paynter NP, Wassink AM, Buring JE, van der Graaf Y, Cook NR. Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. Eur Heart J. 2011 Dec;32(23):2962–9. PMID: 22090661; PMCID: PMC3227855.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e246b2db5d576e9f64ceda68a53e296b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74354c7bf6605d38850b5d67982fbb6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcc52f4a19ebafc676db248786c320c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b0e3f6f0293e112c18a46be22dd1ac6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9fc2040566e687d9f73c3cdebd1d360 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e28a97b52b3cb92c5ab509133c407cbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b470c13653c449e332a1ba6d4f867f62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6559578ce60b5cc44d72af5319761d48
date	201112
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3227855 https://pubmed.ncbi.nlm.nih.gov/22090661 https://doi.org/10.1093/eurheartj/ehr423
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3586 https://portal.issn.org/resource/ISSN/1522-9645 https://portal.issn.org/resource/ISSN/0195-668X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects
discusses	http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0001864
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002318Q000517 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D001241Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D002318Q000401 http://id.nlm.nih.gov/mesh/D020521Q000401 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D020521Q000517 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009203Q000517 http://id.nlm.nih.gov/mesh/D009203Q000401 http://id.nlm.nih.gov/mesh/D006470Q000139 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011322 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D010975Q000009 http://id.nlm.nih.gov/mesh/D001241Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe23f5fc3f1162f1b17ab695c9c450eb http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9585

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 60.